Current status of pulmonary rehabilitation and impact on prognosis of patients with idiopathic pulmonary fibrosis in South Korea
Jung Hyun Nam, Kyung Joo Kim, Chin Kook Rhee, Joon Young Choi, Yong Suk Jo · 2024
Read Current status of pulmonary rehabilitation and impact on prognosis of patients with idiopathic pulmonary fibrosis in South Korea by Jung Hyun Nam, Kyung Joo Kim, Chin Kook Rhee, Joon Young Choi, Yong Suk Jo (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11740027.txt.
Description
Nam and colleagues (2024) used South Korea's national health insurance database to study pulmonary rehabilitation in idiopathic pulmonary fibrosis. This scarring lung disease leaves patients breathless, and rehab programs can ease breathlessness and improve exercise capacity and quality of life. The open question was whether rehab also changes survival. The team counted how often rehab was used after insurance coverage began in 2016, and compared flare-ups and deaths in patients who did and did not receive it.
Of 4,228 patients, only 205, under 5 percent, got rehab. Rehab patients were more often treated with the drug pirfenidone and with steroids. Steroid use itself came with higher death risk in both groups. Among patients not on steroids, rehab showed no clear effect on deaths or flare-ups. The authors call for a prospective study in early-stage patients, since the disease's steady decline may hide any benefit in data like these.
Catalog record
| CREATOR | Jung Hyun Nam, Kyung Joo Kim, Chin Kook Rhee, Joon Young Choi, Yong Suk Jo |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |